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A major constraint in oral controlled drug delivery is that not all drug candidates
are absorbed uniformly throughout the gastrointestinal tract (GIT). Some drugs are ab-
sorbed only in a particular portion of GIT or are absorbed to a different extent in various
segments of GIT. An absorption window exists because of physiological, physicochemical
or biochemical factors. Recent scientific and patent literature reveals increased interest
in novel dosage forms that can be retained in the stomach for a prolonged and predict-
able period of time. One of the most feasible approaches is to control the gastric residen-
ce time using gastroretentive dosage forms (GRDDS) that can provide newer therapeutic
options. GRDDS can improve controlled delivery of drugs by continuously releasing the
drug for a prolonged period of time before it reaches its absorption site, thus ensuring
its optimal bioavailability (1).
The purpose of designing a floating multiple unit dosage form is to develop a reli-
able formulation of loratadine that has all the advantages of a floating single unit dosage
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form but is devoid of disadvantages of single unit dosage forms, namely sticking to or
being obstructed in the gastrointestinal tract. In spite of all sophisticated formulations,
the retention time of the single unit (floating drug delivery system) FDDS depends on
many physiological factors and it is a well known fact that early gastric emptying of a
monolithic device causes rapid lack of therapeutic efficacy, especially with drugs having
an absorption window only in the stomach (2).
Loratadine, a H1 receptor blocker, is absorbed in the proximal part of the gastroin-
testinal tract; it is stable in acidic pH, has a narrow therapeutic absorption window in
the GI tract and the presence of food enhances its bioavailability (3), meeting the prima-
ry criterion for selection of loratadine as the drug candidate to be formulated as a float-
ing multiple unit dosage form.
The low methoxy polysaccharide, pectin, with the degree of esterification less than
50% can form rigid gels by the action of calcium ions or multivalent cations, which cros-
slink the galacturonic acid chains of pectin to yield hydrogels that are stable at low pH.
In this study, the loratadine-loaded gastroretentive emulsion gel beads of calcium pecti-
nate, were developed using selected oils. The release behaviour of the gel beads capable
of floating in gastric fluid was investigated with the aim to achieve a gastroretentive,
multiple unit, controlled release formulation of loratadine.
EXPERIMENTAL
Materials
Loratadine was obtained as a gift sample from Arti Pharmaceuticals, India. Low
methoxy pectin with the degree of esterification of 35% and ethyl cellulose were obtai-
ned from S.D. Fine Chem., India. Light mineral oil and castor oil were obtained from the
Central Drug House, India.
Optimization studies for floating gel beads
In the 23 factorial design (Table 1) used, three factors, namely, the ratio of polymers
(pectin: sodium alginate), percentage of oil (mineral oil/castor oil) and concentration of
cross linking agent (calcium chloride) were selected as independent variables while the
bead size, shape, buoyancy and non leakage of oil from the beads were the response pa-
rameters used for optimization of process variables in preparation of floating gel beads.
Loratadine (1%, m/V) was levigated with sufficient quantity of Tween 20 and the
smooth dispersion formed was transferred into a polymer mixture of pectin/sodium al-
ginate (3:1). The mixture was stirred on a magnetic stirrer for 2 h and emulsified with ei-
ther mineral oil or castor oil separately using Silverson emulsifier (Hicon, India) main-
tained at 500 rpm for 2 min. The drug loaded emulsion was extruded into 0.45 mol L–1
calcium chloride solution maintained under gentle agitation. Loratadine loaded beads
containing either mineral oil (CPAMO) or castor oil (CPACO) were separated, washed
with water and allowed to dry at room temperature for 6 h (4, 5).
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Size and morphology
The mean diameter of loratadine floating gel beads was determined by sieving. The
collected fractions were weighed and the average particle size was determined. External
surface and cross sections of gel beads were studied with a scanning electron microsco-
pe (Joel 6100, Japan). The gel beads and their cross sections were coated with gold-palla-
dium under an argon atmosphere using a gold sputter module in a high vacuum evapo-
rator.
Buoyancy
Seventy mL of each test medium (water, 0.1 mol L–1 HCl, acid phthalate buffer, pH
3.12 and normal saline) was separately agitated on a magnetic stirrer at 75 rpm and 37 °C
and 1 g of the floating beads were incorporated into the test medium (6). The lag time to
float and the floating behavior of the beads in each test medium were observed for a pe-
riod of 12 h.
In vitro drug release
In vitro drug release characteristics of loratadine floating gel beads were evaluated
in both fasted (0.1 mol L–1 HCl, pH 1.25) and fed state (acid phthalate buffer, pH 3.12)
conditions. Dissolution of floating beads was carried out in a Modified Rosette Rice test
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apparatus (7). A glass beaker was modified at the base by adding an 's' shaped glass tu-
be so that the glass beaker can hold 70 mL of dissolution medium. The medium was stir-
red at 75 rpm on a magnetic stirrer and maintained at 37 °C. A burette connected to a re-
servoir was mounted above the beaker to deliver the dissolution medium at a flow rate
of 2 mL min–1. Sampling was done at 0, 0.5, 1.0, 2.0, 3.0, 4.0, 5.0, 6.0, 7.0 and 8.0 h when 5
mL aliquots were withdrawn, suitably diluted and analyzed at 282.5 nm and 273.5 nm
(UV spectrophotometer, Pharmaspec 1700, Shimadzu, Japan) for fasted and fed states,
respectively. The release data was subjected to model fitting using the PCP Disso 2.0
software, Pune, India.
Additionally, an experimental formulation F17 containing 10 mg loratadine and lac-
tose (q.s.) filled in a capsule (# 2) was used as a reference formulation.
Coating of gel beads
22 factorial design (Table II) was used to optimize the coating conditions on the se-
lected floating beads. The coating parameters were 5 and 10% (m/V) ethyl cellulose (EC)
solution in acetone and coating times of 10 and 20 min. Gel beads (2 g) were placed in a
fluidized bed dryer (TG 100, Retsch, Germany) and the coating solution was sprayed
on the fluidized beads using a spray gun for a period of 20 min at an air inlet speed of
220 m s–1 at room temperature. The beads were dried at room temperature for a period
of 24 h until all solvent was evaporated, leaving a film of EC coat on the gel beads.
Evaluation of EC-coated loratadine gel beads
The beads collected at the end of the coating process were weighed and the percentage
increase in mass was calculated. In vitro drug release of the coated beads equivalent to
10 mg of loratadine was carried out in the fed state conditions and the drug release pro-
file obtained was evaluated for model independent parameters. SEM micrograph (Joel
6100, Japan) of the bisected coated beads was used to calculate the coating thickness.
RESULTS AND DISCUSSION
CPAMO and CPACO floating gel beads
Experimental results of the 23 factorial design demonstrated a polymer ratio of
2.5:1.5 (pectin/sodium alginate) by mass, 15% (m/V) of oil (mineral oil or castor oil) and
0.45 mol L–1 CaCl2 solution (cross linking agent) as the optimimum processing condi-
tions for the desired dependent responses. Thus CPAMO and CPACO floating gel beads
of loratadine were prepared by the emulsion gelation method wherein homogenized
emulsion of either mineral oil or castor oil containing polymer mixture was dropped in-
to 0.45 mol L–1 CaCl2 solution; spherical gel beads were formed instantaneously.
Gelation occurred due to intermolecular cross-linking between the divalent calcium
ions and the negatively charged carboxyl groups of pectin and sodium alginate molecu-
les (8). Pectin helped emulsify the mixture of water and oil phase during the homogeni-
zation process and its emulsion stabilization property could be explained by its surfa-
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ce-active ability to reduce the interfacial tension between the oil and water phases. Thus,
formulations F3 (CPAMO) and F11 (CPACO) with spherically shaped beads, uniform size
distribution, buoyant behavior in 0.1 mol L–1 HCl for 12 h, and non leakage of oil at
room temperature (Table I) were selected as optimized formulations.
Morphology
F3 gel beads appeared as white, translucent and rigid, whereas F11 gel beads were
off-white, transparent and elastic (Fig. 1). Gel beads containing mineral oil were not sig-
nificantly smaller in diameter (1.24  0.26 mm) than those incorporating castor oil (1.31 
0.13 mm).The surface of F3 (Fig. 1a) floating gel beads appeared smooth and the presen-
ce of minor projections on the surface of F3 gel beads may be attributed to the presence
of insoluble drug particles in the bead matrix, which was in contrast to F11 beads with a
rough surface (Fig. 1b) with honey-comb like texture without projections on the surface.
The cross sectional studies of F3 (Fig. 2a) and F11 (Fig. 2b) gel beads showed sponge like
structure, corresponding to the egg box where the oil droplets were entrapped. Numer-
ous oil globules of the 0.06  0.03 diameter mm were embedded in the bead matrix pores
of both F3 and F11.
Buoyancy and drug content
F3 and F11 were steeped separately in test solutions water, 0.1 mol L–1 HCl, acid
phthalate buffer, pH 3.12 and normal saline (pH 6.80), of specific gravities 1.007, 1.013,
1.013 and 1.014 g mL–1, respectively. F3 and F11 gel beads floated in all the test media
without any lag time and remained buoyant for 12 h without any signs of degradation
in test solutions. The factors contributing to the floating appeared to be the porous struc-
ture of beads, low relative densities of mineral (0.84 g mL–1) and castor oil (0.98 g mL–1)
as compared to that of gastric media (1.004 g mL–1), facilitation of air entrapment by the
oils and low true density values of F3 (0.9232 g mL–1) and F11 (0.9456 g mL–1).
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a) b)
Fig. 1. Scanning electron micrographs of the external surface of loratadine floating
beads: a) CPAMO and b) CPACO.
F3 exhibited the highest drug loading value of 4.79  0.02 mg per 100 mg whereas
F11 showed the least value of 4.67  0.01 mg per 100 mg of gel beads. Percentage entrap-
ment efficiency was found to be the highest in F3 (67.5  1.2%. This may be attributed to
the highly porous nature of the gel bead matrix, which allowed considerable drug load-
ing while F11 (57.2  1.6 %) supported by fewer pores, as visualized in SEM photog-
raphs (Fig. 2b), showed lower drug entrapment values. Thus, it is suggested that more
porous the matrix, the higher will be the entrapment values, since higher porosity provi-
des larger avenues for entrapment.
In vitro drug release
In vitro drug release study of loratadine gel beads was carried out both in the fasted
state, pH 1.25, and in the fed state, pH 3.12, for a period of 8 h. In the fasted state, gel
beads exhibited a biphasic release profile as an initial rapid drug release phase (burst ef-
fect) was followed by a slower, gradually declining drug release phase after one hour ex-
tending up to 8 h (Fig. 3). F3 and F11 released 80.4  2.0% and 76.0  1.5% loratadine, res-
pectively, within one hour, followed by a sustained release profile for 8 h. Experimental
capsule (F17) formulation containing 10 mg of loratadine, when dissoluted under simi-
lar conditions, released more than 83% of the drug within 1 h but could not sustain the
release over the following 7 h, but rather exhibited a rapid first-order decline. This relea-
se behavior substantiates the use of loratadine emulsion gel beads as a drug delivery
system for modifying the release characteristics of the drug.
Under simulated fed state conditions, loratadine gel beads did not exhibit a burst
release and sustained drug release was observed. The cumulative amount of drug relea-
sed in a sustainable manner, from F3 and F11 was 79.0  1.0% and 73.5  1.2%, respecti-
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a) b)
Fig. 2. Scanning electron micrographs of the internal structure of loratadine
floating beads: a) CPAMO and b) CPACO.
vely, at the end of 8 h (Fig. 3). Absence of burst effect in fed state may be correlated to
the chemical nature of the drug. Being basic in character, it readily dissolves at lower pH
values of the fasted state, but as the pH increases (fed conditions) the solubility reduces.
The dissolution profiles obtained in the fed state indicate concomitant administration of
meals as an essential aspect to obtain the desired controlled release of the gastroretenti-
ve formulation of loratadine. The two-way analysis of variance (ANOVA) revealed a sig-
nificant difference between the in vitro drug release profiles of loratadine in the fed and
fasted states at a 95% confidence interval (p < 0.05).
Various release kinetic models were applied to elucidate the mechanism of drug re-
lease from the floating gel beads in the fed state. Drug release from the optimized for-
mulations F3 and F11 followed the Higuchi (R = 0.9841, n = 0.38) and Peppas models
(R = 0.9827, n = 0.31), respectively, suggesting a diffusion based mechanism of drug re-
lease as the diffusion exponent values were less than 0.45 (9). As characteristic behavior,
mineral oil containing gel beads exhibited a faster release the drug while the beads con-
taining castor oil showed a relatively slow drug release, which may be due to higher
specific gravity and viscosity of castor oil and to greater partitioning of the drug to cas-
tor oil compared to mineral oil.
Nonenteric polymer ethyl cellulose was selected for coating of gel beads due to its
stability in gastric pH and based on the reports on the use of ethyl cellulose for coating
on floating micro particles to modify the drug release (10). F3, which exhibited the high-
est diffusion exponent in fed state conditions, was selected for coating. The desirable de-
pendent response was zero-order release from EC-coated formulation in the fed state.
Fig. 4 shows the comparative drug release profiles of EC-coated loratadine floating gel
beads (F3C1 to F3C4). The release of loratadine from formulation F3C1 gel beads was
the highest, amounting to 64.1  1.7%, whereas formulation F3C4 exhibited the lowest
drug release of 34.5  2.0% at the end of 8 h. It is generally known that the mode of drug
release from gel beads coated with a water insoluble membrane/polymer (reservoir
type), is penetration of liquid, dissolution of the drug to form a saturated solution (as
long as undissolved drug is present) and partitioning of drug into the polymeric mem-
193




























Fig. 3. Drug release profiles of experimental formulation, F3, F11 and F17 in fasted
and fed states (mean  SD, n = 3).
brane, resulting in drug diffusion through the membrane (11). A similar mechanism can
be suggested for the release of loratadine from the floating gel beads.
Dissolution independent parameters for coated beads are tabulated in Table II. Of
all the coated formulations, F3C1 (higher level of EC concentration and higher level of
coating time) exhibited maximum dissolution efficiency of 49.8% after 480 min with
least t50% of 4.03 h and a dissolution profile that best fitted zero-order release with R va-
lue of 0.9744 was optimized as the gastroretentive controlled-release formulation of lora-
tadine. On the other hand, F3C4 (lower level of EC concentration and lower level of coa-
ting time) exhibited the least dissolution efficiency of 22.1% after 480 min with least t50%
of 11.45 h. Other coated beads exhibited intermediate values. Thus both the EC concen-
tration and the time of coating at higher levels were optimized as the coating variables
to obtain the desired response.
The sections of EC coated F3C1 gel beads, when observed under a scanning electron
microscope revealed uniform coating of ethyl cellulose with coating thickness of 0.12 
194
S. K. Mishra and K. Pathak: Formulation and evaluation of oil entrapped gastroretentive floating gel beads of loratadine, Acta Pharm.
58 (2008) 187–197.

















F3C1 10 20 4.03 49.81 0.9744 0.050
F3C2 10 10 4.83 39.68 0.9345 0.042
F3C3 5 20 8.91 30.43 0.9238 0.034
F3C4 5 10 11.45 22.14 0.9513 0.026
























Fig. 4. Drug release profile of
ethyl cellulose coated F3 floa-
ting gel beads in theb fed sta-
te (mean  SD, n = 3).
0.78 mm (Fig. 5) enclosing a highly cross-linked network matrix that could effectively
control the release of loratadine for 8 h. Of all the coated formulations, F3C1 which exhi-
bited maximum dissolution efficiency with least t50% of 4.03 h and a dissolution profile
that best fitted zero-order release with R value of 0.9744, was regarded as an optimized
gastroretentive controlled release formulation of loratadine. Additionally, the first-order
release rate as reported by Saidan et al. (12) that may be used to identify the therapeuti-
cally efficacious dosage form was determined for the EC-coated gel bead formulations.
Formulation F3C1 with the desired release rate value of 0.05 h–1 (Table II) calculated using
the pharmacokinetic parameters of loratadine for twice daily administration was hence
selected as the therapeutically efficacious gastroretentive formulation of loratadine.
CONCLUSIONS
The designed therapeutically efficacious gastroretentive formulation of loratadine
combining an excellent buoyant ability and suitable drug release pattern could possibly
be advantageous in terms of increased bioavailability of loratadine. The system devoid
of disadvantages of a single unit dosage form provided the advantages of ease of prepa-
ration and sustained drug release over several hours.
Acknowledgements. – The authors are thankful to IIT Roorkee, India for providing
SEM facilities.
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Fig. 5. Scanning electron micrograph
of the cross-section of ethyl cellulose
coated F3C1.
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S A @ E T A K
Oblikovanje i vrednovanje plutaju}ih uljnih mikrozrnaca
loratadina s produljenim zadr`avanjem u `elucu
SHASHI KIRAN MISHRA i KAMLA PATHAK
U radu je opisana priprava plutaju}ih mikrozrnaca za kontrolirano osloba|anje lo-
ratadina metodom `eliranja emulzije. Mikrozrnca sadr`e ulja, a njihovo zadr`avanje u
`elucu je produljeno. Priprava mikrozrnaca je optimirana 23 faktorijalnim dizajnom.
Pripravci optimalne sposobnosti plutanja i stabilnosti dobiveni su uz omjer masa pekti-
na i natrijevog alginata 2,5:1,5, udio mineralnog ulja ili ulja kastora 15% (m/V) i koncen-
traciju kalcijevog klorida 0,45 mol L–1. Iz tih se mikrozrnaca loratadin osloba|a in vitro
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tijekom 8 h, a osloba|anje slijedi Peppasov model ako je n < 0,45. Mikrozrnca presvu-
~ena etilcelulozom optimirana 22 faktorijalnim dizajnom slijede kinetiku nultog reda ti-
jekom 8 h.
Klju~ne rije~i: loratadin, zadr`avanje u `elucu, faktorijalni dizajn, presvlaka od etilceluloze, kinetika
nultog reda
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